Next Article in Journal
Pharmacogenetics of SSRIs and Sexual Dysfunction
Next Article in Special Issue
Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies
Previous Article in Journal
Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress
Previous Article in Special Issue
Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties
Open AccessArticle

Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity

1
Department of Medicine, Division of Hematology/Oncology, Case Western Reserve University, Cleveland, OH 44106, USA
2
Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, USA
3
Case Center for Proteomics and Bioinformatics, Case Western Reserve University, Cleveland, OH 44106, USA
4
Department of Ophthalmology, Vision Science Research Center, Case Western Reserve University, Cleveland, OH 44106, USA
5
Division of General Medical Science, Oncology Case Comprehensive Cancer Center, Cleveland, OH 44106, USA
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(12), 3594-3613; https://doi.org/10.3390/ph3123594
Received: 17 November 2010 / Accepted: 1 December 2010 / Published: 15 December 2010
(This article belongs to the Special Issue Cell-penetrating Peptides 2012)
Previously, we developed cell-penetrating penta-peptides (CPP5s). In the present study, VPTLK and KLPVM, two representative CPP5s, were used to characterize the cell-penetration and protein-transduction activities of these small molecules. Various inhibitors of endocytosis and pinocytosis (chlorpromazine, cytochalasin D, Filipin III, amiloride, methyl-b-cyclodextrin, and nocodazole) were tested. Only cytochalasin D showed suppression of CPP5 entry, though the effect was partial. In addition, CPP5s were able to enter a proteoglycan-deficient CHO cell line. These results suggest that pinocytosis and endocytosis may play only a minor role in the cell entry of CPP5s. By mass spectrometry, we determined that the intracellular concentration of VPTLK ranged from 20 nM to 6.0 mM when the cells were cultured in medium containing 1 mM – 1.6 mM VPTLK. To determine the protein-transduction activity of CPP5s, the Tex-LoxP EG cell line, which has a Cre-inducible green fluorescent protein (GFP) gene, was used. VPTLK and KLPVM were added to the N-terminus of Cre, and these fusion proteins were added to the culture medium of Tex-LoxP EG cells. Both VPTLK-Cre and KLPVM-Cre were able to turn on GFP expression in these cells, suggesting that CPP5s have protein-transduction activity. Since CPP5s have very low cytotoxic activity, even at a concentration of 1.6 mM in the medium, CPP5s could be utilized as a new tool for drug delivery into cells. View Full-Text
Keywords: Cell-Penetrating Peptide (CPP), Cell-Penetrating Penta-peptide (CPP5), Bax Inhibiting Peptide (BIP), Protein Transduction, Ku70, Bax, Apoptosis, Drug Delivery Cell-Penetrating Peptide (CPP), Cell-Penetrating Penta-peptide (CPP5), Bax Inhibiting Peptide (BIP), Protein Transduction, Ku70, Bax, Apoptosis, Drug Delivery
Show Figures

Figure 1

MDPI and ACS Style

Gomez, J.A.; Chen, J.; Ngo, J.; Hajkova, D.; Yeh, I.-J.; Gama, V.; Miyagi, M.; Matsuyama, S. Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity. Pharmaceuticals 2010, 3, 3594-3613.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop